The impact of chronic kidney disease on medication choice and pharmacologic management in patients with heart failure

Expert Review of Clinical Pharmacology
Syed Raza Shah, David E Winchester

Abstract

In the past few years, medical community, including doctors, have become increasingly aware of the fact that chronic kidney disease (CKD) and heart failure (HF) have common risk factors which impact one another in terms of choice of therapy. Areas covered: Management of these two diseases has been a challenge for physicians. The treatment goals for HF patients with CKD are very important. They serve as the end point in using a specific treatment for management and treatment of CKD patients, hence decreasing mortality rates. In this review, we discuss the pharmacological approaches to managing patients with HF and CKD, discussing current evidence-based up-to-date management strategies and guidelines in the general population with HF and CKD. Expert commentary: Newer novel drugs targeting specific signaling pathways are approaching the stages of clinical investigation including the direct renin inhibitors. They have been a highly attractive concept for the future in the management of these patients. However, while advances in technology elucidated many aspects of these diseases, many mysteries still remain. With continued research, we can expect more cost-effective and patient-friendly drug therapies to be developed in the near f...Continue Reading

References

Dec 1, 1981·The Journal of Endocrinology·J StaessenA Amery
Feb 20, 1997·The New England Journal of Medicine·UNKNOWN Digitalis Investigation Group
Jun 26, 1998·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·M OzkahyaE J Dorhout Mees
Jul 13, 1999·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·A LevinO Djurdjev
Feb 11, 2000·Annals of the New York Academy of Sciences·B A Schwetz
Sep 22, 2001·The New England Journal of Medicine·B M BrennerUNKNOWN RENAAL Study Investigators
Jan 5, 2002·The New England Journal of Medicine·J N CohnUNKNOWN Valsartan Heart Failure Trial Investigators
Jan 5, 2002·The New England Journal of Medicine·K T Weber
Sep 13, 2002·Journal of the American College of Cardiology·Maylene WongUNKNOWN Val-HeFT Heart Failure Trial Investigators
Feb 4, 2003·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Peter A McCulloughMichael P Hudson
Apr 2, 2003·The New England Journal of Medicine·Bertram PittUNKNOWN Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators
May 14, 2003·Journal of the American College of Cardiology·Gennaro CiceRaffaele Calabrò
Nov 12, 2003·The New England Journal of Medicine·Marc A PfefferUNKNOWN Valsartan in Acute Myocardial Infarction Trial Investigators
Jul 31, 2004·Journal of the American Society of Nephrology : JASN·Michael G ShlipakHarlan M Krumholz
Aug 6, 2004·The New England Journal of Medicine·Biff F Palmer
Oct 19, 2004·Journal of the American College of Cardiology·Justin EzekowitzUNKNOWN APPROACH Investigators
Dec 15, 2004·Archives of Internal Medicine·Kevin C AbbottGeorge L Bakris
Jun 13, 2006·The American Journal of Cardiology·Shervin EshaghianGregg C Fonarow
Nov 17, 2006·The New England Journal of Medicine·Tilman B DrüekeUNKNOWN CREATE Investigators
Dec 30, 2006·Circulation·Wayne RosamondUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Aug 28, 2007·European Journal of Heart Failure·Vic HasselbladKirkwood F Adams
Aug 1, 2009·Journal of the American College of Cardiology·Nicola C EdwardsJonathan N Townend
Aug 27, 2009·Journal of Cardiovascular Medicine·Nicola AcquaronePaolo Bellotti

❮ Previous
Next ❯

Citations

Nov 30, 2018·Expert Review of Clinical Pharmacology·Syed Raza ShahSteven Roark
Nov 21, 2019·Molecular Medicine Reports·Ying ZhangLing Nie

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Circulation Journal : Official Journal of the Japanese Circulation Society
Yusuke Sata, Henry Krum
Anesthesia and Analgesia
Leanne Groban, John Butterworth
Reviews in Cardiovascular Medicine
Mihai GheorghiadeChristopher M O'Connor
Postgraduate Medical Journal
N Burns-Cox, C Gingell
PharmacoEconomics
Luca Degli Esposti, Giorgia Valpiani
© 2022 Meta ULC. All rights reserved